Agilent Technologies, Inc. (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and Danaher Corporation, both of which are prominent in the same industry.
On November 25, 2025, UBS maintained its "Buy" rating for Agilent, with a "hold" action, indicating confidence in the company's future performance. At the time, Agilent's stock was priced at $153.60. UBS also raised its price target from $170 to $180, as highlighted by TheFly, suggesting potential for further growth.
Agilent's recent Q4 2025 earnings call, held on November 24, 2025, featured key figures like CEO Padraig McDonnell and CFO Adam Elinoff. The call provided insights into the company's financial performance and strategic direction. Analysts from major financial institutions, including UBS, participated, reflecting the company's strong engagement with the financial community.
The stock price of Agilent is currently $153.60, marking a 1.55% increase or $2.35. The stock has fluctuated between $150.47 and $153.60 today. Over the past year, it reached a high of $153.84 and a low of $96.43, indicating significant volatility. Agilent's market capitalization is approximately $43.55 billion, with a trading volume of 2,000,123 shares.
